COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Biden Administration recently released a series of Executive Orders (EOs) related to the COVID-19 pandemic. One EO includes provisions for the Department of Labor and the Occupational Safety and Health Administration (OSHA) to consider whether an Emergency Temporary Standard (ETS), including鈥
The Food and Drug Administration issued an emergency use authorization for the first serology test to identify individuals with neutralizing antibodies from recent or prior infection with the virus that causes COVID-19.
The Department of Health and Human Services should fully reinstate its June COVID-19 Provider Relief Fund reporting requirements, AHA said again today in a letter to the agency.
The Centers for Disease Control and Prevention updated its recommended practices to prevent and control infection in health care settings during the COVID-19 pandemic.
Pregnant women with COVID-19 are more likely than their non-pregnant counterparts to be admitted to an intensive care unit, receive invasive ventilation, extracorporeal membrane oxygenation or die, according to a study of 461,825 women with symptomatic COVID-19 released by the Centers for Disease鈥
The Food and Drug Administration reminded clinical laboratory staff and health care providers to follow recommended steps to prevent false positive results from antigen tests for the COVID-19 virus, citing reports of false positives in nursing homes and other settings.
The Centers for Disease Control and Prevention would like to partner with one or more organizations to enable centralized reporting from COVID-19 testing entities to public health departments, the agency said this week in a request for information.
The Food and Drug Administration, Customs and Border Protection, and Immigration and Customs Enforcement Oct. 30 announced a memorandum of understanding to maximize inspection and detection capabilities in order to prevent harmful products from entering the U.S. through international mail鈥
AHA letter urging the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with 鈥渇requently changing and confusing鈥 COVID-19 data collection efforts.
The Department of Health and Human Services issued an important clarification to its Oct. 22 reporting requirements for providers that received Provider Relief Fund payments.